Coya Therapeutics (COYA) Return on Sales (2023 - 2026)
Coya Therapeutics (COYA) posted Return on Sales of 0.29% for Q1 2026, down 1226.31% sequentially from 0.02% in Q4 2025, and little changed YoY from 0.29% in Q1 2025.
Coya Therapeutics (COYA) Return on Sales (2023 - 2026) Analysis & Trends
Coya Therapeutics has reported Return on Sales for 4 years, with the latest figure at 0.29% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (up 5.0% YoY) and the FY2025 annual result came in at 0.03%, up 2.0% from the prior year.
- Return on Sales declined to 0.29% in Q1 2026 per COYA's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q4 2023 and troughed at 62.55% in Q4 2024.
- A 4-year average of 6.4% and a median of 0.15% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales tumbled 6254 bps in 2024, then jumped 6253 bps in 2025.
- Over 4 years, Return on Sales stood at 0.01% in 2023, then plunged by 985280 bps to 62.55% in 2024, then jumped by 100 bps to 0.02% in 2025, then tumbled by 1226 bps to 0.29% in 2026.
- According to Business Quant data, Return on Sales over the past three periods registered 0.29%, 0.02%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Coya Therapeutics | 113.53 Mn | 70.33 Mn | - | -0.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.27% |
| Mar 31, 2026 | -0.29% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.37% |
| Mar 31, 2025 | -0.28% |
| Dec 31, 2024 | -62.55% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.40% |
| Dec 31, 2023 | -0.01% |